Sophie Kornowski-Bonnet

Dr. Sophie Kornowski-Bonnet is a Chairman at Corium LLC (Massachusetts), a Senior Partner at Gurnet Point Capital LLC and a President & Director at BP Asset IX, Inc. She is on the Board of Directors at Maze Therapeutics, Inc., Syngenta AG, Même Cosmetics SAS, Alladapt Immunotherapeutics, Inc., Crossover Health, Inc., Fairtility Ltd., Mahana Therapeutics, Inc., Teal Bio, Inc., Syngenta Bangladesh Ltd. and BP Asset IX, Inc. Dr. Kornowski-Bonnet was previously employed as a Non-Executive Director by Idorsia Ltd., a General Manager by Ridoret Distribution SARL, and a Chairman & Chief Executive Officer by Boston Pharmaceuticals, Inc. She also served on the board at Chugai Pharmaceutical Co., Ltd. She received her MBA from The University of Chicago.